Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FL-115 by Suzhou Forlong Biotechnology for Solid Tumor: Likelihood of Approval
FL-115 is under clinical development by Suzhou Forlong Biotechnology and currently in Phase I for Solid Tumor. According to GlobalData,...